$JAZZ Jazz Pharmaceuticals plc Insider Trading Week 19/2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Jazz Pharmaceuticals plc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Jazz Pharmaceuticals plc in week 19/2015.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 14 2015 | JAZZ | Jazz Pharmaceutica ... | Young Matthew P. | EVP & CFO | Payment of Exercise | F | 176.60 | 801 | 141,457 | 27,662 | 28.5 K to 27.7 K (-2.81 %) |
May 14 2015 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP & General Couns ... | Option Exercise | M | 46.83 | 2,073 | 97,079 | 46,632 | |
May 14 2015 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP & General Couns ... | Sell | S | 173.85 | 4,000 | 695,400 | 46,297 | 50.3 K to 46.3 K (-7.95 %) |
May 14 2015 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP & General Couns ... | Buy | M | 46.83 | 2,073 | 97,079 | 50,297 | 48.2 K to 50.3 K (+4.30 %) |
May 14 2015 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Sell | S | 173.85 | 5,000 | 869,250 | 551,967 | 557 K to 552 K (-0.90 %) |
May 14 2015 | JAZZ | Jazz Pharmaceutica ... | O'Keefe Kenneth W | Director | Option Exercise | M | 46.83 | 4,500 | 210,735 | 0 | |
May 14 2015 | JAZZ | Jazz Pharmaceutica ... | O'Keefe Kenneth W | Director | Sell | S | 174.90 | 1,218 | 213,026 | 9,432 | 10.7 K to 9.4 K (-11.44 %) |
May 14 2015 | JAZZ | Jazz Pharmaceutica ... | O'Keefe Kenneth W | Director | Buy | M | 46.83 | 4,500 | 210,735 | 10,650 | 6.2 K to 10.7 K (+73.17 %) |
May 14 2015 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Sell | S | 175.10 | 6 | 1,051 | 4,356 | 4.4 K to 4.4 K (-0.14 %) |
May 14 2015 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Sell | S | 173.85 | 644 | 111,959 | 4,362 | 5 K to 4.4 K (-12.86 %) |
May 14 2015 | JAZZ | Jazz Pharmaceutica ... | Gray Peter | Director | Sell | S | 175.15 | 7 | 1,226 | 4,946 | 5 K to 4.9 K (-0.14 %) |
May 14 2015 | JAZZ | Jazz Pharmaceutica ... | Gray Peter | Director | Sell | S | 173.85 | 697 | 121,173 | 4,953 | 5.7 K to 5 K (-12.34 %) |
May 13 2015 | JAZZ | Jazz Pharmaceutica ... | Smith Karen L. | Global Head of R&D ... | Option Exercise | A | 176.51 | 15,516 | 2,738,729 | 15,516 | |
May 13 2015 | JAZZ | Jazz Pharmaceutica ... | Smith Karen L. | Global Head of R&D ... | Option Exercise | A | 176.51 | 2,264 | 399,619 | 2,264 | |
May 13 2015 | JAZZ | Jazz Pharmaceutica ... | Smith Karen L. | Global Head of R&D ... | Grant | A | 0.00 | 275 | 0 | 7,105 | 6.8 K to 7.1 K (+4.03 %) |
May 13 2015 | JAZZ | Jazz Pharmaceutica ... | Smith Karen L. | Global Head of R&D ... | Grant | A | 0.00 | 6,830 | 0 | 6,830 | 0 to 6.8 K |
May 13 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 176.63 | 60 | 10,598 | 6,089 | 6.1 K to 6.1 K (-0.98 %) |
May 13 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 175.98 | 137 | 24,109 | 6,149 | 6.3 K to 6.1 K (-2.18 %) |
May 13 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 176.64 | 3,022 | 533,800 | 303,911 | 306.9 K to 303.9 K (-0.98 %) |
May 13 2015 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 175.98 | 6,781 | 1,193,289 | 306,933 | 313.7 K to 306.9 K (-2.16 %) |